Search Results

Viewing Page 2 of 22 | Showing Results 11 - 20 of 219

AMPLATZER™ PFO Occluder Post Approval Study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post...

Sameer Gafoor, MD

A Randomized Controlled Trial of Vitamin D Supplementation in Multiple Sclerosis.

Low vitamin D levels have been shown to increase a person's risk of developing multiple sclerosis (MS), and patients with MS who have lower vitamin...

Peiqing Qian, MD

A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis

To compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing multiple sclerosis
Pavle Repovic, MD, PhD

Swedish MS Center

AEGIS-II: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

Brief Summary: This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and...

John L. Petersen II, MD

GUIDE-HF: Hemodynamic-GUIDEd Management of Heart Failure

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population...

John Mignone, MD, PhD

Irrigated Radio Frequency Ablation to Terminate Non-Paroxysmal Atrial Fibrillation (Terminate AF Study)

This is a multi-center, single-arm, prospective, non-randomized, interventional study. A maximum of 160 subjects will be treated at up to 15...

Dr. Eric Lehr

HEART-FID - A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency

This is a double-blind, multicenter, prospective, randomized, placebo-controlled study to assess the effects of IV FCM compared to placebo on the...

John Mignone, MD, PhD

Consonance - AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple...

Pavle Repovic, MD

Gamma Knife Thalamotomy for Treatment of Essential Tremor

The purpose of this study is to examine effects (good and bad) of gamma knife radiosurgery for essential tremor. The gamma knife places a small...

Christopher Loiselle, M.D.

Swedish Cancer Institute

Viewing Page 2 of 22 | Showing Results 11 - 20 of 219